Stephen Baxter
Stock Analyst at Wells Fargo
(3.86)
# 1,945
Out of 4,707 analysts
704
Total ratings
51.4%
Success rate
4.5%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Maintained: Hold | $166 | $171.89 | -3.43% | 36 | Sep 9, 2026 | |
| CVS CVS Health | Maintained: Buy | $123 | $96.07 | +28.03% | 51 | Aug 26, 2026 | |
| MOH Molina Healthcare | Maintained: Hold | $220 | $196.30 | +12.07% | 55 | Aug 26, 2026 | |
| LMRI Lumexa Imaging Holdings | Maintained: Buy | $19 | $11.54 | +64.64% | 4 | Aug 14, 2026 | |
| OSCR Oscar Health | Rated: Hold | $20 → $27 | $33.01 | -18.21% | 32 | Aug 13, 2026 | |
| CAH Cardinal Health | Rated: Buy | $256 → $277 | $240.49 | +15.18% | 22 | Aug 12, 2026 | |
| COR Cencora | Rated: Buy | $331 → $395 | $324.69 | +21.65% | 23 | Aug 11, 2026 | |
| MCK McKesson | Rated: Hold | $812 → $933 | $889.12 | +4.94% | 26 | Aug 11, 2026 | |
| CON Concentra Group Holdings Parent | Rated: Buy | $28 → $40 | $33.88 | +18.06% | 11 | Aug 11, 2026 | |
| MDLN Medline | Rated: Hold | $47 → $34 | $34.69 | -1.99% | 5 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $46 | $39.31 | +17.02% | 12 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $141 → $146 | $91.37 | +59.79% | 26 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $369 → $381 | $402.02 | -5.23% | 33 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 | $62.56 | +24.68% | 23 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $305 → $307 | $275.83 | +11.30% | 40 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $231 → $281 | $259.06 | +8.47% | 33 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $502 | $403.09 | +24.54% | 61 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $397 → $526 | $400.84 | +31.22% | 51 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $391 → $473 | $401.94 | +17.68% | 49 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $56 → $69 | $64.58 | +6.84% | 51 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $2 | $2.84 | -29.58% | 28 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $6.26 | +27.80% | 17 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $40 | $13.34 | n/a | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $235 | $324.86 | n/a | 6 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $88 → $91 | $590.89 | n/a | 2 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $116 | $235.50 | n/a | 1 | Apr 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $203 | $280.76 | n/a | 1 | Feb 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $259.21 | n/a | 1 | Nov 14, 2019 |
Universal Health Services
Sep 9, 2026
Maintained: Hold
Price Target: $166
Current: $171.89
Upside: -3.43%
CVS Health
Aug 26, 2026
Maintained: Buy
Price Target: $123
Current: $96.07
Upside: +28.03%
Molina Healthcare
Aug 26, 2026
Maintained: Hold
Price Target: $220
Current: $196.30
Upside: +12.07%
Lumexa Imaging Holdings
Aug 14, 2026
Maintained: Buy
Price Target: $19
Current: $11.54
Upside: +64.64%
Oscar Health
Aug 13, 2026
Rated: Hold
Price Target: $20 → $27
Current: $33.01
Upside: -18.21%
Cardinal Health
Aug 12, 2026
Rated: Buy
Price Target: $256 → $277
Current: $240.49
Upside: +15.18%
Cencora
Aug 11, 2026
Rated: Buy
Price Target: $331 → $395
Current: $324.69
Upside: +21.65%
McKesson
Aug 11, 2026
Rated: Hold
Price Target: $812 → $933
Current: $889.12
Upside: +4.94%
Concentra Group Holdings Parent
Aug 11, 2026
Rated: Buy
Price Target: $28 → $40
Current: $33.88
Upside: +18.06%
Medline
Aug 11, 2026
Rated: Hold
Price Target: $47 → $34
Current: $34.69
Upside: -1.99%
Aug 10, 2026
Rated: Buy
Price Target: $45 → $46
Current: $39.31
Upside: +17.02%
Aug 10, 2026
Maintained: Buy
Price Target: $141 → $146
Current: $91.37
Upside: +59.79%
Aug 3, 2026
Rated: Hold
Price Target: $369 → $381
Current: $402.02
Upside: -5.23%
Aug 3, 2026
Maintained: Buy
Price Target: $78
Current: $62.56
Upside: +24.68%
Jul 31, 2026
Rated: Hold
Price Target: $305 → $307
Current: $275.83
Upside: +11.30%
Jul 31, 2026
Rated: Buy
Price Target: $231 → $281
Current: $259.06
Upside: +8.47%
Jul 29, 2026
Rated: Buy
Price Target: $502
Current: $403.09
Upside: +24.54%
Jul 17, 2026
Rated: Buy
Price Target: $397 → $526
Current: $400.84
Upside: +31.22%
Jul 16, 2026
Rated: Buy
Price Target: $391 → $473
Current: $401.94
Upside: +17.68%
Jul 13, 2026
Maintained: Hold
Price Target: $56 → $69
Current: $64.58
Upside: +6.84%
Apr 27, 2026
Rated: Sell
Price Target: $2
Current: $2.84
Upside: -29.58%
Oct 29, 2025
Maintained: Hold
Price Target: $8
Current: $6.26
Upside: +27.80%
May 1, 2024
Maintained: Hold
Price Target: $4 → $40
Current: $13.34
Upside: n/a
Jan 11, 2021
Downgraded: Hold
Price Target: $235
Current: $324.86
Upside: n/a
May 13, 2020
Downgraded: Hold
Price Target: $88 → $91
Current: $590.89
Upside: n/a
Apr 27, 2020
Upgraded: Hold
Price Target: $116
Current: $235.50
Upside: n/a
Feb 18, 2020
Upgraded: Buy
Price Target: $203
Current: $280.76
Upside: n/a
Nov 14, 2019
Upgraded: Buy
Price Target: n/a
Current: $259.21
Upside: n/a